Ensign Peak Advisors
KYMR icon

Ensign Peak Advisors’s Kymera Therapeutics KYMR Stock Holding History

Ensign Peak Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2M Sell
97,660
-16,182
-14% -$1.39M 0.02% 417
2026
Q1 		$9.48M Buy
113,842
+18,795
+20% +$1.49M 0.02% 422
2025
Q4 		$7.4M Buy
95,047
+3,150
+3% +$213K 0.01% 462
2025
Q3 		$5.2M Hold
91,897
– – 0.01% 581
2025
Q2 		$4.01M Buy
+91,897
New +$3.16M 0.01% 690
2024
Q1 		– Sell
-40,207
Closed -$1.02M – 1738
2023
Q4 		$1.02M Hold
40,207
– – ﹤0.01% 1363
2023
Q3 		$559K Hold
40,207
– – ﹤0.01% 1557
2023
Q2 		$924K Hold
40,207
– – ﹤0.01% 1329
2023
Q1 		$1.19M Hold
40,207
– – ﹤0.01% 1100
2022
Q4 		$1M Sell
40,207
-7,340
-15% -$196K ﹤0.01% 1159
2022
Q3 		$1.03M Buy
47,547
+1,130
+2% +$29.8K ﹤0.01% 1050
2022
Q2 		$914K Sell
46,417
-12,863
-22% -$300K ﹤0.01% 1158
2022
Q1 		$2.51M Hold
59,280
– – 0.01% 798
2021
Q4 		$3.76M Buy
59,280
+26,540
+81% +$1.55M 0.01% 750
2021
Q3 		$1.92M Sell
32,740
-30,000
-48% -$1.74M ﹤0.01% 1153
2021
Q2 		$3.04M Hold
62,740
– – 0.01% 877
2021
Q1 		$2.44M Buy
62,740
+42,740
+214% +$2.57M 0.01% 1007
2020
Q4 		$1.24M Hold
20,000
– – ﹤0.01% 1308
2020
Q3 		$646K Buy
+20,000
New +$611K ﹤0.01% 1458

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Ensign Peak Advisors's KYMR Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Kymera Therapeutics (KYMR) stake by 14% in Q2 2026, selling an estimated $1.39M and leaving 97,660 shares worth $11.2M. The position accounts for 0.02% of the portfolio, ranked #417.

Ensign Peak Advisors first reported a position in KYMR in Q3 2020 and has held it in 19 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Ensign Peak Advisors held 97,660 shares of Kymera Therapeutics worth $11.2M as of Q2 2026.
  • Ensign Peak Advisors sold 16,182 Kymera Therapeutics shares in Q2 2026, an estimated $1.39M.
  • Kymera Therapeutics made up 0.02% of Ensign Peak Advisors's portfolio in Q2 2026, its #417 holding.
  • Ensign Peak Advisors first reported a position in Kymera Therapeutics in Q3 2020 and has held it in 19 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.